In a recent development, the FDA has authorized certain nicotine products to be marketed with a modified risk claim. This authorization applies to 20 ZYN nicotine pouches.

The FDA's decision allows these products to be labeled as having a modified risk. Further information about this authorization is available from the source.

Details about the implications of this decision can be found through additional reporting from the source, providing more context and information about the modified risk claim for the 20 authorized ZYN nicotine pouches.